Shanmuga Hospital Limited Reports Full Utilization of IPO Proceeds
Shanmuga Hospital Limited has announced complete utilization of its IPO proceeds of Rs 2,061.72 crore. Funds were allocated to capital expenditure (Rs 1,452.50 lakhs), issue-related expenses (Rs 225.94 lakhs), and general corporate purposes (Rs 383.28 lakhs). The remaining Rs 1,115.50 lakhs was used in May 2025 to purchase a robotic surgical machine. As of September 30, 2025, the company reported total assets of Rs 5,449.34 lakhs and shareholders' funds of Rs 4,170.93 lakhs. The fund utilization was reviewed by the Audit Committee and approved by the Board of Directors, complying with SEBI regulations.
*this image is generated using AI for illustrative purposes only.
Shanmuga Hospital Limited , formerly known as Shanmuga Hospital Private Limited, has announced the complete utilization of its Initial Public Offer (IPO) proceeds. The company, which raised Rs 2,061.72 crore through its IPO, has provided a detailed account of how the funds were allocated and spent.
IPO Proceeds Allocation
The company's IPO funds were distributed across three main categories:
| Object of Issue | Amount (Rs in Lakhs) |
|---|---|
| Capital Expenditure | 1,452.50 |
| Issue Related Expenses | 225.94 |
| General Corporate Purposes | 383.28 |
| Total | 2,061.72 |
Utilization of Funds
According to the statement filed by Shanmuga Hospital Limited, the company had fully utilized the IPO proceeds by September 30, 2025. The remaining unutilized amount of Rs 1,115.50 lakhs as of March 31, 2025, was completely used during May 2025 for a significant capital expenditure - the purchase and installation of a robotic surgical machine.
Transparency and Compliance
The company's statement on fund utilization was reviewed by the Audit Committee and approved by the Board of Directors on November 12, 2025. This process aligns with the regulatory requirements set by the Securities and Exchange Board of India (SEBI) under Regulation 32 of the SEBI Listing Obligations and Disclosure Requirements.
Financial Position
As of September 30, 2025, Shanmuga Hospital Limited reported:
- Total assets of Rs 5,449.34 lakhs
- Shareholders' funds, including share capital and reserves, totaling Rs 4,170.93 lakhs
Management Commentary
Dr. Panneerselvam Prabu Sankar, Executive Director & CEO of Shanmuga Hospital Limited, signed off on the financial statements, indicating the management's approval of the reported figures and fund utilization.
Auditor's Review
The external auditors, PPN and Company, certified that there were no deviations in the use of public issue proceeds for the reporting period. Their limited review report stated that nothing has come to their attention that causes them to believe the financial statements are not in accordance with applicable accounting standards and SEBI regulations.
This comprehensive report on the utilization of IPO proceeds demonstrates Shanmuga Hospital Limited's commitment to transparency and its focus on strategic investments, particularly in advanced medical technology such as robotic surgical equipment. The full utilization of funds within the specified timeframe may be seen as a positive indicator of the company's ability to execute its growth plans effectively.
Historical Stock Returns for Shanmuga Hospital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +14.28% | +3.16% | -6.59% | +11.84% | -17.15% | -17.15% |
19
